|1.71||+0.10 / +6.21%|
Data as of 4:02pm ET
|1.71||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +75.44% increase from the last price of 1.71.
The current consensus among 2 polled investment analysts is to Buy stock in Navidea Biopharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.